Citius Pharmaceuticals, Inc. — Cash Flow Charts
61 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-175.3% -$8M
$-13M
Free Cash Flow↓-175.3% -$8M
$-13M
Investing Cash Flow
$-4M
Financing Cash Flow↑+711.1% +$18M
$21M
Capex
$0
Stock-Based Comp↑+69.5% +$2M
$4M
Debt Issued
$10M
Debt Repaid
$0
D&A↓-100.0% -$578
$0
SBC Allocated Expense↑+69.5% +$2M
$4M
SBC Unrecognized Cost↓-82.3% -$995K
$213K